These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4824912)

  • 1. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW; Lawrence DK
    Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 3. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW; Lawrence DK
    J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice.
    Lawrence DK; Pertwee RG; Gill EW; Piper JM
    Biochem Pharmacol; 1974 Nov; 23(21):3017-27. PubMed ID: 4429599
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
    Levy S; McCallum NK
    Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
    Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
    Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism.
    Widman M; Nordqvist M; Dollery CT; Briant RH
    J Pharm Pharmacol; 1975 Nov; 27(11):842-8. PubMed ID: 1493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
    Siemens AJ; Kalant H
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
    Magour S; Coper H; Fähndrich C; Hill R
    Life Sci; 1976 Mar; 18(6):575-84. PubMed ID: 1263740
    [No Abstract]   [Full Text] [Related]  

  • 13. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
    Jones G; Pertwee RG
    Br J Pharmacol; 1972 Jun; 45(2):375-7. PubMed ID: 5048656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of di- and tri-substituted hydroxy and ketone metabolites of delta1-tetrahydrocannabinol in mouse liver.
    Harvey DJ; Martin BR; Paton WD
    J Pharm Pharmacol; 1977 Aug; 29(8):482-6. PubMed ID: 19597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons.
    McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH
    Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond.
    Harvey DJ; Martin BR; Paton WD
    J Pharm Pharmacol; 1977 Aug; 29(8):495-7. PubMed ID: 19600
    [No Abstract]   [Full Text] [Related]  

  • 17. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites.
    Jones G; Widman M; Agurell S; Lindgren JE
    Acta Pharm Suec; 1974 Jun; 11(3):283-94. PubMed ID: 4839738
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass fragmentographic assay for 11-hydroxy-delta 9-tetrahydrocannabinol from plasma.
    Rosenfeld JM; Taguchi VY
    Anal Chem; 1976 Apr; 48(4):726-9. PubMed ID: 1259165
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
    Dewey WL; McMillan DE; Harris LS; Turk RF
    Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.